NXP Semiconductors NV (NASDAQ:NXPI), Voltari Corp. (NASDAQ:VLTC) and Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) kicked off the first week of March with big gains. Pacira Pharmaceuticals Inc. (NASDAQ:PCRX), Seventy Seven Energy Inc. (NYSE:SSE) and Navient Corporation (NASDAQ:NAVI) took dives.
NXP Semiconductors Rallies on Freescale Acquisition
NXP Semiconductors NV rallied +17.27% this Monday in the wake of an announcement that it will acquire Freescale for $11.8 billion. With 3.45% of his publicly equity portfolio allocated to NXPI as of Q4, Leon Cooperman will get a boost off of the news.
Parica Pharmaceuticals Tumbles on FDA Rejection
Pacira Pharmaceuticals tumbled -19.58% in the wake of news that the FDA has rejected its application to expand the use of its post-surgery pain drug, Exparel. George Soros is taking a hit on this one.
Seventy Seven Energy plunged -9.58% this Monday, putting its YTD loss at -19.78% and its performance since going public at -82.39%. Carl Icahn wound up with a stake in the firm after it spun off of Chesapeake Energy and maintained his position in Q4.